Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57810
Full metadata record
DC FieldValueLanguage
dc.creatorMaria Isabel Achatzpt_BR
dc.creatorMaira Caleffipt_BR
dc.creatorRodrigo Guindalinipt_BR
dc.creatorRenato Moretti Marquespt_BR
dc.creatorAngélica Nogueira Rodriguespt_BR
dc.creatorPatricia Ashton-Prollapt_BR
dc.date.accessioned2023-08-14T20:19:47Z-
dc.date.available2023-08-14T20:19:47Z-
dc.date.issued2020-01-21-
dc.citation.volume1pt_BR
dc.citation.issue6pt_BR
dc.citation.spage439pt_BR
dc.citation.epage452pt_BR
dc.identifier.doi10.1200/JGO.19.00170pt_BR
dc.identifier.issn2687-8941pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57810-
dc.description.resumoPURPOSE:The objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC.METHODS: A selected panel of Brazilian experts in fields related to HBOC was provided with a series of relevant questions to address before the multiday conference. During this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved.RESULTS: The authors propose specific and realistic recommendations for improving access to early diagnosis,risk management, and cancer care of HBOC specific to Brazil. Moreover, in creating these recommendations, the authors strived to address all the barriers and impediments mentioned in this article. CONCLUSION: There is a great need to expand hereditary cancer testing and counseling in Brazil, and changing current policies is essential to accomplishing this goal. Increased knowledge and awareness, together with regulatory actions to increase access to this technology, have the potential to improve patient care and prevention and treatment efforts for patients with cancer across the count.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofGlobal Oncology-
dc.rightsAcesso Abertopt_BR
dc.subjectDiagnosispt_BR
dc.subjectBrazilpt_BR
dc.subjectHereditary Breast and Ovarian Cancer Syndromept_BR
dc.subjectWomen's Healthpt_BR
dc.subjectOvarian Neoplasmspt_BR
dc.subject.otherSíndrome Hereditária de Câncer de Mama e Ováriopt_BR
dc.subject.otherSaúde da mulherpt_BR
dc.subject.otherBrasilpt_BR
dc.subject.otherDiagnósticopt_BR
dc.subject.otherNeoplasias Ovarianaspt_BR
dc.titleRecommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazilpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://ascopubs.org/doi/full/10.1200/JGO.19.00170pt_BR
Appears in Collections:Artigo de Periódico



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.